SBIR/STTR Research Award

Newborn Infant Vision Test

Award identifier 5cfdedbd35b4c603ec554373c1ae96b18e063ae0f8efafc9d86dbae13161460bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,056,419

Program and phase

STTR · Phase II

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Precision Vision, Inc.
Proposal award date
2016-09-30
Contract end date
2019-08-31
UEI
U4MLAD49NYR6
Solicitation number
PA15-270
Topic code
N

Research abstract

Project Summary! This STTR Phase II project continues the development of the Newborn Acuity Cardstm and the Newborn Contrast Cardstm Together these Newborn Cards form a new clinical test of visual acuity and contrast sensi tivity for use on newborn full term and preterm infants The stimuli are square wave gratings which the examiner presents to the infant in a fixation and following protocol and determines from the infantandapos s looking behavior whether he she saw each stimulus or not An infantandapos s visual acuity or contrast sensitivity is the highest spatial frequency or lowest contrast the least visible stimulus he she can see The proposed Phase II work will include a training study in which the best method for training examiners in the use of the cards will be established and documented The project will also establish age norms by meas uring visual acuity and contrast sensitivity on a large sample of healthy full term and preterm infants Because the test is so new it is not known how reliable the measurements are Therefore this project will include re peated testing of individual newborn infants on different days by different examiners The Intraclass Correla tion Coefficient will determine whether measurement of an infantandapos s level of visual function produces results that are more related to the infantandapos s vision rather than to the more ephemeral characteristics of the infantandapos s alertness or the skill of the examiner The clinical utility of the test its sensitivity and specificity in detecting vision disor ders has not been established so this project will explore these parameters by testing a sample of infants with and without Retinopathy of Prematurity ROP ROP is not the only serious visual disorder experienced by newborn infants but it is one of the most prevalent and most serious This is not a clinical trial but the results on infants with varying stages of ROP will be a good indicator of whether the Newborn Acuity Cards and Newborn Contrast Cards are sensitive and specific indicators of healthy visual function The results on the ROP infants will also be used in conjunction with the age norms to establish a normal cutoff value for a screening test of only a few cards which will further increase the convenience of this noninvasive test The Newborn Contrast Cards and Newborn Acuity Cards will allow the physician to monitor the vision of patients in the Neonatal Intensive Care Unit and other pediatric settings in cases where the visual disorder is progressing as in Retinopathy of Prematurity or Cortical Vision Impairment or where the disorder may be treated Its potential market includes hospitals neonatologists pediatricians and pediatric ophthalmologists around the world In of cases of childhood blindness in the U S the blinding disorder is present in the neonatal period and the inability to see well may be the only sign of a blinding disorder in half of those cases Ultimately we want every newborn infantandapos s vision to be screened and every premature infantandapos s vision to be tested more thoroughly and this project will be the next step towards making this plan a reality Project Narrative This project will continue the development a clinical test of visual acuity and contrast sensitivity for use with newborn and premature infants in the Neonatal Intensive Care unit and other pediatric settings In of cases of childhood blindness and visual impairment in the U S the blinding disorder is present in the neonatal period and the inability to see well is the only sign of the disorder in about half of those cases Here we investigate the repeatability of the test age norms for gestational ages weeks and the clinical utility of the test in cases of Retinopathy of Prematurity

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

2 SBIR/STTR records share this UEI (2012–2016). Reported award amounts total $1,182,682. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.